Bioline Reagents Overview
- Founded
-
1992

- Status
-
Acquired/Merged
- Employees
-
58

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$23.8M
Bioline Reagents General Information
Description
Manufacturer and distributor of specialized bio-research reagents intended to simplify, accelerate and improve life sciences research. The company produces and supplies antibodies, viral antigens and critical assay reagents, providing customers with a range of products which are fast and easy to use, guaranteed to work and developed by scientists who understand what our customers are trying to achieve so they can focus on their scientific goals
Contact Information
Website
www.bioline.com
Formerly Known As
Quantace Limited
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Parent Company
Primary Office
- Unit 16 The Edge Business Centre
- Humber Road
- London NW2 6EW
- England, United Kingdom
+44 020 0000 0000
Bioline Reagents Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 20-Jul-2010 | $23.8M | 000.00 | Completed | Generating Revenue | |
1. Accelerator/Incubator | Completed | Generating Revenue |
Bioline Reagents Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer and distributor of specialized bio-research reagents intended to simplify, accelerate and improve life scie
Biotechnology
London, United Kingdom
58
As of 2016
00.00
0000-00-00
000000&0
Bioline Reagents Competitors (38)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
R-Biopharm | Private Equity-Backed | Darmstadt, Germany | 0000 | 00000000000 | ||
000000 | Formerly VC-backed | Oxford, United Kingdom | 00 | 000.00 | 000000&0 | 000.00 |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
0000000000 0000000 | Formerly PE-Backed | Beit Haemek, Israel | 000 | 0000 | 000000&0 | 0000 |
000000000 00000000 | Private Debt Financed | Hamburg, Germany | 000 | 000.00 | 000000000 | 000.00 |
Bioline Reagents Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
John Kenny | Chief Executive Officer & Board Member | ||
Alan Parker | Finance Director & Board Member |
Bioline Reagents Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Alan Parker | Bioline Reagents | Finance Director & Board Member | 000 0000 |
John Kenny | Bioline Reagents | Chief Executive Officer & Board Member | 000 0000 |
Bioline Reagents Signals
Bioline Reagents Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Cicada Innovations | Accelerator/Incubator | 000 0000 | 000000 0 |